CHOLESTYRAMINE
Cholestyramine for Oral Suspension, USP
Approved
Approval ID
d82647da-465b-4e2e-8cf8-72d50f047b3e
Product Type
HUMAN PRESCRIPTION DRUG LABEL
Effective Date
Mar 17, 2023
Manufacturers
FDA
PURACAP LABORATORIES LLC DBA BLU PHARMACEUTICALS
DUNS: 080210964
Products 1
Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.
cholestyramine
Product Details
FDA regulatory identification and product classification information
FDA Identifiers
NDC Product Code24658-266
Application NumberANDA074557
Product Classification
M
Marketing Category
C73584
G
Generic Name
cholestyramine
Product Specifications
Route of AdministrationORAL
Effective DateMarch 17, 2023
FDA Product Classification
INGREDIENTS (12)
CHOLESTYRAMINEActive
Quantity: 4 g in 9 g
Code: 4B33BGI082
Classification: ACTIB
FD&C YELLOW NO. 6Inactive
Code: H77VEI93A8
Classification: IACT
ANHYDROUS CITRIC ACIDInactive
Code: XF417D3PSL
Classification: IACT
D&C YELLOW NO. 10Inactive
Code: 35SW5USQ3G
Classification: IACT
FRUCTOSEInactive
Code: 6YSS42VSEV
Classification: IACT
PECTINInactive
Code: 89NA02M4RX
Classification: IACT
AMMONIUM GLYCYRRHIZATEInactive
Code: 3VRD35U26C
Classification: IACT
ORANGEInactive
Code: 5EVU04N5QU
Classification: IACT
PROPYLENE GLYCOL ALGINATEInactive
Code: 26CD3J2R0C
Classification: IACT
SORBITOLInactive
Code: 506T60A25R
Classification: IACT
SUCROSEInactive
Code: C151H8M554
Classification: IACT
XANTHAN GUMInactive
Code: TTV12P4NEE
Classification: IACT